News

Lung cancer is a dangerous disease that ranks first in cancer mortality in Korea, and there are few initial symptoms, making ...
Findings indicate that frequent COVID-19 booster shots do not weaken T-cell responses, alleviating concerns for vulnerable ...
A new understanding of how tumours exploit our nervous system is leading to new ways to treat cancer using familiar drugs ...
Fifteen companies skyrocketed by double to triple digits last week, buoyed by fresh company-specific developments and a ...
Cellnex’s long-term contracts and share buybacks support a bullish outlook for the stock. Read more on what investors should ...
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...
A growing number of college students are trading in their smartphones for what’s now considered trendy hardware: flip phones.
For over a decade, scientists have been growing organoids - small clusters of cells that mimic a particular organ - to serve ...
Also in the Cleveland Heights blotter, police arrested for disorderly conduct a man whose dislike of his neighbor's dog got ...
A Falmouth teen, Jayden Wilsey, is the first to receive gene therapy to treat sickle cell at Boston Children's Hospital.
Tarlatamab prolonged both overall and progression-free survival in the treatment of small cell lung cancer, backing it as a ...